Molecular and biological hallmarks of ageing

British Journal of Surgery

Volumn 103, Issue 2, 2016, Pages e29-e46

  Aunan, J R ^a   Watson, M M ^a   Hagland, H R ^a,b   Soreide K ^a,b,c  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF STAVANGER   (Norway)

^c UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT STEM CELL; AGING; CELL AGING; CELL COMMUNICATION; GENETIC EPIGENESIS; GENETICS; GENOMIC INSTABILITY; HUMAN; LIFE EXPECTANCY; MITOCHONDRIAL DISEASES; NUTRITION; PHYSIOLOGY; PROTEOSTASIS DEFICIENCIES; TELOMERE;

ADULT STEM CELLS; AGING; CELL AGING; CELL COMMUNICATION; EPIGENESIS, GENETIC; GENOMIC INSTABILITY; HUMANS; LIFE EXPECTANCY; MITOCHONDRIAL DISEASES; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; PROTEOSTASIS DEFICIENCIES; TELOMERE;

EID: 84954508690     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.10053     Document Type: Review

References (148)

1. Kaeberlein M., Longevity and aging. F1000Prime Rep 2013; 5: 5.
2. Troen BR,. The biology of aging. Mt Sinai J Med 2003; 70: 3-22.
3. Kraehling JR, Sessa WC,. Enhanced eNOS activation as the fountain of youth for vascular disease: is BPIFB4 what Ponce de Leõn was looking for? Circ Res 2015; 117: 309-310.
4. Brun CE, Rudnicki MA,. GDF11 and the mythical fountain of youth. Cell Metab 2015; 22: 54-56.
5. de Cabo R, Carmona-Gutierrez D, Bernier M, Hall MN, Madeo F,. The search for antiaging interventions: from elixirs to fasting regimens. Cell 2014; 157: 1515-1526.
6. Liu J, Finkel T,. Aging: the blurry line between life and death. Curr Biol 2014; 24: R610-R613.
7. The truth about testosterone replacement therapy. Fountain of youth-or harbinger of health woes? Johns Hopkins Med Lett Health After 50 2014; 29: 1-2.
8. Novella S, Dantas AP, Segarra G, Medina P, Hermenegildo C,. Vascular aging in women: is estrogen the fountain of youth? Front Physiol 2012; 3: 165.
9. Badugu S, Anderson W,. Dopamine as the fountain of youth? Restoring decision making ability in older adults. Neurosurgery 2013; 73: N19-N20.
10. Rachul CM, Percec I, Caulfield T,. The fountain of stem cell-based youth? Online portrayals of anti-aging stem cell technologies. Aesthetic Surg J 2015; 35: 730-736.
11. Mathers CD, Stevens GA, Boerma T, White RA, Tobias MI,. Causes of international increases in older age life expectancy. Lancet 2015; 385: 540-548.
12. Prince MJ, Wu F, Guo Y, Gutierrez Robledo LM, O'Donnell M, Sullivan R, et al., The burden of disease in older people and implications for health policy and practice. Lancet 2015; 385: 549-562.
13. Moskalev AA, Shaposhnikov MV, Plyusnina EN, Zhavoronkov A, Budovsky A, Yanai H, et al., The role of DNA damage and repair in aging through the prism of Koch-like criteria. Ageing Res Rev 2013; 12: 661-684.
14. Pitt JN, Kaeberlein M,. Why is aging conserved and what can we do about it? PLoS Biol 2015; 13: e1002131.
15. Longo VD, Antebi A, Bartke A, Barzilai N, Brown-Borg HM, Caruso C, et al., Interventions to slow aging in humans: are we ready? Aging Cell 2015; 14: 497-510.
16. Lõpez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G,. The hallmarks of aging. Cell 2013; 153: 1194-1217.
17. Kennedy BK, Berger SL, Brunet A, Campisi J, Cuervo AM, Epel ES, et al., Geroscience: linking aging to chronic disease. Cell 2014; 159: 709-713.
18. Hanahan D, Weinberg RA,. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-674.
19. Hanahan D, Weinberg RA,. The hallmarks of cancer. Cell 2000; 100: 57-70.
20. Friedberg EC,. DNA damage and repair. Nature 2003; 421: 436-440.
21. Kryston TB, Georgiev AB, Pissis P, Georgakilas AG,. Role of oxidative stress and DNA damage in human carcinogenesis. Mutat Res 2011; 711: 193-201.
22. Reeves SG, Meldrum C, Groombridge C, Spigelman A, Suchy J, Kurzawski G, et al., DNA repair gene polymorphisms and risk of early onset colorectal cancer in Lynch syndrome. Cancer Epidemiol 2012; 36: 183-189.
23. Ogino S, Chan AT, Fuchs CS, Giovannucci E,. Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut 2011; 60: 397-411.
24. Lombard DB, Chua KF, Mostoslavsky R, Franco S, Gostissa M, Alt FW,. DNA repair, genome stability, and aging. Cell 2005; 120: 497-512.
25. van Heemst D, den Reijer PM, Westendorp RG,. Ageing or cancer: a review on the role of caretakers and gatekeepers. Eur J Cancer 2007; 43: 2144-2152.
26. +/sirtuin counteract the hallmarks of aging. Front Biosci (Landmark Ed) 2014; 19: 1300-1319.
27. Heydari AR, Unnikrishnan A, Lucente LV, Richardson A,. Caloric restriction and genomic stability. Nucleic Acids Res 2007; 35: 7485-7496.
28. Slyskova J, Lorenzo Y, Karlsen A, Carlsen MH, Novosadova V, Blomhoff R, et al., Both genetic and dietary factors underlie individual differences in DNA damage levels and DNA repair capacity. DNA Repair (Amst) 2014; 16: 66-73.
29. Xie Z, Jay KA, Smith DL, Zhang Y, Liu Z, Zheng J, et al., Early telomerase inactivation accelerates aging independently of telomere length. Cell 2015; 160: 928-939.
30. Pusceddu I, Farrell CJ, Di Pierro AM, Jani E, Herrmann W, Herrmann M,. The role of telomeres and vitamin D in cellular aging and age-related diseases. Clin Chem Lab Med 2015; 53: 1661-1678.
31. Hayflick L, Moorhead PS,. The serial cultivation of human diploid cell strains. Exp Cell Res 1961; 25: 585-621.
32. Olovnikov AM,. Telomeres, telomerase, and aging: origin of the theory. Exp Gerontol 1996; 31: 443-448.
33. Cawthon RM, Smith KR, O'Brien E, Sivatchenko A, Kerber RA,. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 2003; 361: 393-395.
34. Blasco MA,. Telomere length, stem cells and aging. Nat Chem Biol 2007; 3: 640-649.
35. Pereira B, Ferreira MG,. Sowing the seeds of cancer: telomeres and age-associated tumorigenesis. Curr Opin Oncol 2013; 25: 93-98.
36. Honig LS, Kang MS, Cheng R, Eckfeldt JH, Thyagarajan B, Leiendecker-Foster C, et al., Heritability of telomere length in a study of long-lived families. Neurobiol Aging 2015; 36: 2785-2790.
37. Kuszel L, Trzeciak T, Richter M, Czarny-Ratajczak M,. Osteoarthritis and telomere shortening. J Appl Genet 2015; 56: 169-176.
38. Carlquist JF, Knight S, Cawthon RM, Le VT, Bunch TJ, Horne BD, et al., Shortened telomere length is associated with paroxysmal atrial fibrillation among cardiovascular patients enrolled in the Intermountain Heart Collaborative Study. Heart Rhythm 2015; doi: 10.1016/j.hrthm.2015.07.032/.
39. Hunt SC, Kimura M, Hopkins PN, Carr JJ, Heiss G, Province MA, et al., Leukocyte telomere length and coronary artery calcium. Am J Cardiol 2015; 116: 214-218.
40. Bocklandt S, Lin W, Sehl ME, Sánchez FJ, Sinsheimer JS, Horvath S, et al., Epigenetic predictor of age. PLoS One 2011; 6: e14821.
41. Koch CM, Wagner W,. Epigenetic-aging-signature to determine age in different tissues. Aging (Albany NY) 2011; 3: 1018-1027.
42. Hannum G, Guinney J, Zhao L, Zhang L, Hughes G, Sadda S, et al., Genome-wide methylation profiles reveal quantitative views of human aging rates. Mol Cell 2013; 49: 359-367.
43. Marioni RE, Shah S, McRae AF, Chen BH, Colicino E, Harris SE, et al., DNA methylation age of blood predicts all-cause mortality in later life. Genome Biol 2015; 16: 25.
44. Horvath S, Erhart W, Brosch M, Ammerpohl O, von Schonfels W, Ahrens M, et al., Obesity accelerates epigenetic aging of human liver. Proc Natl Acad Sci U S A 2014; 111: 15 538-15 543.
45. Das C, Tyler JK,. Histone exchange and histone modifications during transcription and aging. Biochim Biophys Acta 2013; 1819: 332-342.
46. Kozomara A, Griffiths-Jones S,. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 2011; 39: D152-D157.
47. Lu J, Clark AG,. Impact of microRNA regulation on variation in human gene expression. Genome Res 2012; 22: 1243-1254.
48. Bonifacio LN, Jarstfer MB,. MiRNA profile associated with replicative senescence, extended cell culture, and ectopic telomerase expression in human foreskin fibroblasts. PLoS One 2010; 5: e12519.
49. Barzilai N, Huffman DM, Muzumdar RH, Bartke A,. The critical role of metabolic pathways in aging. Diabetes 2012; 61: 1315-1322.
50. Kenyon CJ,. The genetics of ageing. Nature 2010; 464: 504-512.
51. Aalaei-Andabili SH, Rezaei N,. MicroRNAs (MiRs) precisely regulate immune system development and function in immunosenescence process. Int Rev Immunol 2015; [Epub ahead of print].
52. GBD 2013 DALYs and HALE Collaborators, Murray CJ, Barber RM, Foreman KJ, Abbasoglu Ozgoren A, Abd-Allah F, Abera SF, et al., Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet 2015; 386: 2145-2191.
53. Zane L, Sharma V, Misteli T,. Common features of chromatin in aging and cancer: cause or coincidence? Trends Cell Biol 2014; 24: 686-694.
54. Hagland HR, Berg M, Jolma IW, Carlsen A, Søreide K,. Molecular pathways and cellular metabolism in colorectal cancer. Dig Surg 2013; 30: 12-25.
55. Issa JP,. Aging and epigenetic drift: a vicious cycle. J Clin Invest 2014; 124: 24-29.
56. Marttila S, Kananen L, Hayrynen S, Jylhava J, Nevalainen T, Hervonen A, et al., Ageing-associated changes in the human DNA methylome: genomic locations and effects on gene expression. BMC Genomics 2015; 16: 179.
57. Eisenstein M., Molecular biology: remove, reuse, recycle. Nature 2014; 514: S2-S4.
58. Labbadia J, Morimoto RI,. The biology of proteostasis in aging and disease. Annu Rev Biochem 2015; 84: 435-464.
59. Clark AR, Lubsen NH, Slingsby C,. sHSP in the eye lens: crystallin mutations, cataract and proteostasis. Int J Biochem Cell Biol 2012; 44: 1687-1697.
60. Koga H, Kaushik S, Cuervo AM,. Protein homeostasis and aging: the importance of exquisite quality control. Ageing Res Rev 2011; 10: 205-215.
61. Huang J, Xie Y, Sun X, Zeh HJ III, Kang R, Lotze MT, et al., DAMPs, ageing, and cancer: the 'DAMP hypothesis'. Ageing Res Rev 2015; 24: 3-16.
62. Qu B, Jia Y, Liu Y, Wang H, Ren G, Wang H,. The detection and role of heat shock protein 70 in various nondisease conditions and disease conditions: a literature review. Cell Stress Chaperones 2015; 20: 885-892.
63. McConnell KW, Fox AC, Clark AT, Chang NY, Dominguez JA, Farris AB, et al., The role of heat shock protein 70 in mediating age-dependent mortality in sepsis. J Immunol 2011; 186: 3718-3725.
64. Chondrogianni N, Sakellari M, Lefaki M, Papaevgeniou N, Gonos ES,. Proteasome activation delays aging in vitro and in vivo. Free Radic Biol Med 2014; 71: 303-320.
65. Chondrogianni N, Petropoulos I, Franceschi C, Friguet B, Gonos ES,. Fibroblast cultures from healthy centenarians have an active proteasome. Exp Gerontol 2000; 35: 721-728.
66. Madeo F, Zimmermann A, Maiuri MC, Kroemer G,. Essential role for autophagy in life span extension. J Clin Invest 2015; 125: 85-93.
67. Glick D, Barth S, Macleod KF,. Autophagy: cellular and molecular mechanisms. J Pathol 2010; 221: 3-12.
68. Morselli E, Maiuri MC, Markaki M, Megalou E, Pasparaki A, Palikaras K, et al., Caloric restriction and resveratrol promote longevity through the Sirtuin-1-dependent induction of autophagy. Cell Death Dis 2010; 1: e10.
69. Rubinsztein DC, Mariño G, Kroemer G,. Autophagy and aging. Cell 2011; 146: 682-695.
70. Nicoli ER, Dumitrescu T, Uscatu CD, Popescu FD, Streaţə I, Serban Şoşoi S, et al., Determination of autophagy gene ATG16L1 polymorphism in human colorectal cancer. Rom J Morphol Embryol 2014; 55: 57-62.
71. Qin Z, Xue J, He Y, Ma H, Jin G, Chen J, et al., Potentially functional polymorphisms in ATG10 are associated with risk of breast cancer in a Chinese population. Gene 2013; 527: 491-495.
72. Carames B, Olmer M, Kiosses WB, Lotz MK,. The relationship of autophagy defects to cartilage damage during joint aging in a mouse model. Arthritis Rheumatol 2015; 67: 1568-1576.
73. Chen K, Yang YH, Jiang SD, Jiang LS,. Decreased activity of osteocyte autophagy with aging may contribute to the bone loss in senile population. Histochem Cell Biol 2014; 142: 285-295.
74. Tan CC, Yu JT, Tan MS, Jiang T, Zhu XC, Tan L,. Autophagy in aging and neurodegenerative diseases: implications for pathogenesis and therapy. Neurobiol Aging 2014; 35: 941-957.
75. Catalgol B, Batirel S, Taga Y, Ozer NK,. Resveratrol: French paradox revisited. Front Pharmacol 2012; 3: 141.
76. Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, Flurkey K, et al., Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 2009; 460: 392-395.
77. Wilkinson JE, Burmeister L, Brooks SV, Chan CC, Friedline S, Harrison DE, et al., Rapamycin slows aging in mice. Aging Cell 2012; 11: 675-682.
78. Neff F, Flores-Dominguez D, Ryan DP, Horsch M, Schröder S, Adler T, et al., Rapamycin extends murine lifespan but has limited effects on aging. J Clin Invest 2013; 123: 3272-3291.
79. Vidal RL, Matus S, Bargsted L, Hetz C,. Targeting autophagy in neurodegenerative diseases. Trends Pharmacol Sci 2014; 35: 583-591.
80. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, et al., Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006; 444: 337-342.
81. Eisenberg T, Knauer H, Schauer A, Büttner S, Ruckenstuhl C, Carmona-Gutierrez D, et al., Induction of autophagy by spermidine promotes longevity. Nat Cell Biol 2009; 11: 1305-1314.
82. Barzilai N, Ferrucci L,. Insulin resistance and aging: a cause or a protective response? J Gerontol A Biol Sci Med Sci 2012; 67: 1329-1331.
83. Pesce V, Cormio A, Fracasso F, Vecchiet J, Felzani G, Lezza AMS, et al., Age-related mitochondrial genotypic and phenotypic alterations in human skeletal muscle. Free Radic Biol Med 2001; 30: 1223-1233.
84. Riera CE, Dillin A,. Tipping the metabolic scales towards increased longevity in mammals. Nat Cell Biol 2015; 17: 196-203.
85. Fontana L, Partridge L, Longo VD,. Extending healthy life span-from yeast to humans. Science 2010; 328: 321-326.
86. Samuels Y, Waldman T,. Oncogenic mutations of PIK3CA in human cancers. Curr Top Microbiol Immunol 2010; 347: 21-41.
87. Cypser JR, Kitzenberg D, Park S-K,. Dietary restriction in C. elegans: recent advances. Exp Gerontol 2013; 48: 1014-1017.
88. Lam YY, Peterson CM, Ravussin E,. Resveratrol vs. Calorie restriction: data from rodents to humans. Exp Gerontol 2013; 48: 1018-1024.
89. Anton S, Leeuwenburgh C,. Fasting or caloric restriction for healthy aging. Exp Gerontol 2013; 48: 1003-1005.
90. Scheen AJ,. The future of obesity: new drugs versus lifestyle interventions. Expert Opin Investig Drugs 2008; 17: 263-267.
91. Ingram DK, Roth GS,. Calorie restriction mimetics: can you have your cake and eat it, too? Ageing Res Rev 2015; 20: 46-62.
92. Rothberg AE, Halter JB,. Obesity and diabetes in an aging population: time to rethink definitions and management? Clin Geriatr Med 2015; 31: 1-15, vii.
93. Mitterberger MC, Mattesich M, Zwerschke W,. Bariatric surgery and diet-induced long-term caloric restriction protect subcutaneous adipose-derived stromal/progenitor cells and prolong their life span in formerly obese humans. Exp Gerontol 2014; 56: 106-113.
94. Alosco ML, Cohen R, Spitznagel MB, Strain G, Devlin M, Crosby RD, et al., Older age does not limit postbariatric surgery cognitive benefits: a preliminary investigation. Surg Obesity Relat Dis 2014; 10: 1196-1201.
95. Lee C, Longo VD,. Fasting vs dietary restriction in cellular protection and cancer treatment: from model organisms to patients. Oncogene 2011; 30: 3305-3316.
96. Zhang Z, Guo M, Zhao S, Xu W, Shao J, Zhang F, et al., The update on transcriptional regulation of autophagy in normal and pathologic cells: a novel therapeutic target. Biomed Pharmacother 2015; 74: 17-29.
97. Haynes CM, Fiorese CJ, Lin YF,. Evaluating and responding to mitochondrial dysfunction: the mitochondrial unfolded-protein response and beyond. Trends Cell Biol 2013; 23: 311-318.
98. Pellegrino MW, Nargund AM, Haynes CM,. Signaling the mitochondrial unfolded protein response. Biochim Biophys Acta 2013; 1833: 410-416.
99. Lane RK, Hilsabeck T, Rea SL,. The role of mitochondrial dysfunction in age-related diseases. Biochim Biophys Acta 2015; 1847: 1837-1400.
100. Sharma K, Le N, Alotaibi M, Gewirtz DA,. Cytotoxic autophagy in cancer therapy. Int J Mol Sci 2014; 15: 10 034-10 051.
101. Nunn AVW, Bell JD, Guy GW,. Lifestyle-induced metabolic inflexibility and accelerated ageing syndrome: insulin resistance, friend or foe? Nutr Metab (Lond) 2009; 6: 16.
102. Dobashi Y, Watanabe Y, Miwa C, Suzuki S, Koyama S,. Mammalian target of rapamycin: a central node of complex signaling cascades. Int J Clin Exp Pathol 2011; 4: 476-495.
103. Shaw RJ,. LKB1 and AMP-activated protein kinase control of mTOR signalling and growth. Acta Physiol (Oxf) 2009; 196: 65-80.
104. Hall JA, Dominy JE, Lee Y, Puigserver P,. The sirtuin family's role in aging and age-associated pathologies. J Clin Invest 2013; 123: 973-979.
105. Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y, et al., Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 2004; 303: 2011-2015.
106. Harman D., Origin and evolution of the free radical theory of aging: a brief personal history, 1954-2009. Biogerontology 2009; 10: 773-781.
107. Munkacsy E, Rea SL,. The paradox of mitochondrial dysfunction and extended longevity. Exp Gerontol 2014; 56: 221-233.
108. Rea SL, Ventura N, Johnson TE,. Relationship between mitochondrial electron transport chain dysfunction, development, and life extension in Caenorhabditis elegans. PLoS Biol 2007; 5: e259.
109. Nakada K, Sato A, Hayashi J,. Mitochondrial functional complementation in mitochondrial DNA-based diseases. Int J Biochem Cell Biol 2009; 41: 1907-1913.
110. Yun J, Finkel T,. Mitohormesis. Cell Metab 2014; 19: 757-766.
111. Yang W, Hekimi S,. A mitochondrial superoxide signal triggers increased longevity in Caenorhabditis elegans. PLoS Biol 2010; 8: e1000556.
112. Yee C, Yang W, Hekimi S,. The intrinsic apoptosis pathway mediates the pro-longevity response to mitochondrial ROS in C. Elegans. Cell 2014; 157: 897-909.
113. Hekimi S, Lapointe J, Wen Y,. Taking a 'good' look at free radicals in the aging process. Trends Cell Biol 2011; 21: 569-576.
114. Durieux J, Wolff S, Dillin A,. The cell-non-autonomous nature of electron transport chain-mediated longevity. Cell 2011; 144: 79-91.
115. Onken B, Driscoll M,. Metformin induces a dietary restriction-like state and the oxidative stress response to extend C. elegans healthspan via AMPK, LKB1, and SKN-1. PLoS One 2010; 5: e8758.
116. Caldeira da Silva CC, Cerqueira FM, Barbosa LF, Medeiros MH, Kowaltowski AJ,. Mild mitochondrial uncoupling in mice affects energy metabolism, redox balance and longevity. Aging Cell 2008; 7: 552-560.
117. Rose G, Crocco P, De Rango F, Montesanto A, Passarino G,. Further support to the uncoupling-to-survive theory: the genetic variation of human UCP genes is associated with longevity. PLoS One 2011; 6: e29650.
118. Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, Puigserver P,. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 2005; 434: 113-118.
119. Lauritzen KH, Kleppa L, Aronsen JM, Eide L, Carlsen H, Haugen ØP, et al., Impaired dynamics and function of mitochondria caused by mtDNA toxicity leads to heart failure. Am J Physiol Heart Circ Physiol 2015; 309: H434-H449.
120. van Gisbergen MW, Voets AM, Starmans MH, de Coo IF, Yadak R, Hoffmann RF, et al., How do changes in the mtDNA and mitochondrial dysfunction influence cancer and cancer therapy? Challenges, opportunities and models. Mutat Res 2015; 764: 16-30.
121. van Deursen JM,. The role of senescent cells in ageing. Nature 2014; 509: 439-446.
122. Campisi J., Aging, cellular senescence, and cancer. Annu Rev Physiol 2013; 75: 685-705.
123. Kuilman T, Michaloglou C, Mooi WJ, Peeper DS,. The essence of senescence. Genes Dev 2010; 24: 2463-2479.
124. Newgard CB, Sharpless NE,. Coming of age: molecular drivers of aging and therapeutic opportunities. J Clin Invest 2013; 123: 946-950.
125. Tchkonia T, Zhu Y, van Deursen J, Campisi J, Kirkland JL,. Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J Clin Invest 2013; 123: 966-972.
126. Dimri GP,. What has senescence got to do with cancer? Cancer Cell 2005; 7: 505-512.
127. Collado M, Blasco MA, Serrano M,. Cellular senescence in cancer and aging. Cell 2007; 130: 223-233.
128. Tian XL, Li Y,. Endothelial cell senescence and age-related vascular diseases. J Genet Genomics 2014; 41: 485-495.
129. Sikora E, Bielak-Zmijewska A, Mosieniak G,. Cellular senescence in ageing, age-related disease and longevity. Curr Vasc Pharmacol 2014; 12: 698-706.
130. Waaijer ME, Gunn DA, Adams PD, Pawlikowski JS, Griffiths CE, van Heemst D, et al., P16INK4a positive cells in human skin are indicative of local elastic fiber morphology, facial wrinkling, and perceived age. J Gerontol A Biol Sci Med 2015; [Epub ahead of print].
131. Krishnamurthy J, Torrice C, Ramsey MR, Kovalev GI, Al-Regaiey K, Su L, et al., Ink4a/Arf expression is a biomarker of aging. J Clin Invest 2004; 114: 1299-1307.
132. Ressler S, Bartkova J, Niederegger H, Bartek J, Scharffetter-Kochanek K, Jansen-Durr P, et al., p16INK4A is a robust in vivo biomarker of cellular aging in human skin. Aging Cell 2006; 5: 379-389.
133. Jeck WR, Siebold AP, Sharpless NE,. Review: a meta-analysis of GWAS and age-associated diseases. Aging Cell 2012; 11: 727-731.
134. Boquoi A, Arora S, Chen T, Litwin S, Koh J, Enders GH,. Reversible cell cycle inhibition and premature aging features imposed by conditional expression of p16Ink4a. Aging Cell 2015; 14: 139-147.
135. Baker DJ, Wijshake T, Tchkonia T, LeBrasseur NK, Childs BG, van de Sluis B, et al., Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 2011; 479: 232-236.
136. Hoenicke L, Zender L,. Immune surveillance of senescent cells-biological significance in cancer- and non-cancer pathologies. Carcinogenesis 2012; 33: 1123-1126.
137. Kang TW, Yevsa T, Woller N, Hoenicke L, Wuestefeld T, Dauch D, et al., Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature 2011; 479: 547-551.
138. Sagiv A, Krizhanovsky V,. Immunosurveillance of senescent cells: the bright side of the senescence program. Biogerontology 2013; 14: 617-628.
139. Pera A, Campos C, Lõpez N, Hassouneh F, Alonso C, Tarazona R, et al., Immunosenescence: implications for response to infection and vaccination in older people. Maturitas 2015; 82: 50-55.
140. Coppé JP, Desprez PY, Krtolica A, Campisi J,. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol 2010; 5: 99-118.
141. Burton DG, Krizhanovsky V,. Physiological and pathological consequences of cellular senescence. Cell Mol Life Sci 2014; 71: 4373-4386.
142. Du Y, Karvellas CJ, Baracos V, Williams DC, Khadaroo RG,; Acute Care and Emergency Surgery (ACES) Group. Sarcopenia is a predictor of outcomes in very elderly patients undergoing emergency surgery. Surgery 2014; 156: 521-527.
143. Szarc vel Szic K, Declerck K, Vidakovic M, Vanden Berghe W,. From inflammaging to healthy aging by dietary lifestyle choices: is epigenetics the key to personalized nutrition? Clin Epigenetics 2015; 7: 33.
144. Giunta S., Exploring the complex relations between inflammation and aging (inflamm-aging): anti-inflamm-aging remodelling of inflamm-aging, from robustness to frailty. Inflamm Res 2008; 57: 558-563.
145. Capri M, Yani SL, Chattat R, Fortuna D, Bucci L, Lanzarini C, et al., Pre-operative, high-IL-6 blood level is a risk factor of post-operative delirium onset in old patients. Front Endocrinol (Lausanne) 2014; 5: 173.
146. Kalinkovich A, Livshits G,. Sarcopenia-the search for emerging biomarkers. Ageing Res Rev 2015; 22: 58-71.
147. Howlett SE, Rockwood K,. Ageing: develop models of frailty. Nature 2014; 512: 253.
148. Cevenini E, Caruso C, Candore G, Capri M, Nuzzo D, Duro G, et al., Age-related inflammation: the contribution of different organs, tissues and systems. How to face it for therapeutic approaches. Curr Pharm Des 2010; 16: 609-618.